Gammagard S/D

Gammagard S/D is a human normal immunoglobulin solution for intravenous use, designed to support immune function. This product is manufactured by Baxalta Innovations GmbH and is sourced from the EU.

Gammagard S/D is primarily used to treat conditions related to immune system deficiencies. It is often administered to individuals who have a weakened immune system or those who are at risk of infections due to low immunoglobulin levels. This medication can help in managing various immune-related disorders by providing essential antibodies.

Common effects of Gammagard S/D may include mild to moderate reactions at the injection site, such as redness or swelling. Some individuals might experience flu-like symptoms, including headache, fever, or muscle aches. These effects are generally temporary and subside as the body adjusts to the medication.

Gammagard S/D should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or pre-existing conditions before starting treatment. Always follow the prescribed dosage and administration guidelines to minimize potential risks.

Gammagard S/D may interact with certain medications, including those that affect the immune system. It is advisable to discuss all current medications with your healthcare provider to avoid potential interactions. Additionally, alcohol consumption should be moderated while using this product.